BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2515494)

  • 21. Treatment of idiopathic erectile dysfunction in men with the opiate antagonist naltrexone--a double-blind study.
    Brennemann W; Stitz B; Van Ahlen H; Brensing KA; Klingmüller D
    J Androl; 1993; 14(6):407-10. PubMed ID: 8294223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical treatment of erectile dysfunction: randomised double blind placebo controlled trial of cream containing aminophylline, isosorbide dinitrate, and co-dergocrine mesylate.
    Gomaa A; Shalaby M; Osman M; Eissa M; Eizat A; Mahmoud M; Mikhail N
    BMJ; 1996 Jun; 312(7045):1512-5. PubMed ID: 8646143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of low testosterone on response to treatment with tadalafil 5 mg once daily for erectile dysfunction.
    Goldfischer ER; Kim ED; Seftel AD; Baygani SK; Burns PR
    Urology; 2014 Jun; 83(6):1326-33. PubMed ID: 24726311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of sildenafil citrate on the male sexual experience assessed with the Sexual Experience Questionnaire: a multicenter, double-blind, placebo-controlled trial with open-label extension.
    Jones LA; Klimberg IW; McMurray JG; Padula R; Tseng LJ; Stecher VJ
    J Sex Med; 2008 Aug; 5(8):1955-64. PubMed ID: 18564150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of tadalafil treatment on erectile function recovery following bilateral nerve-sparing radical prostatectomy: a randomised placebo-controlled study (REACTT).
    Montorsi F; Brock G; Stolzenburg JU; Mulhall J; Moncada I; Patel HR; Chevallier D; Krajka K; Henneges C; Dickson R; Büttner H
    Eur Urol; 2014 Mar; 65(3):587-96. PubMed ID: 24169081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of medroxyprogesterone acetate on subjective arousal, arousal to erotic stimulation, and nocturnal penile tumescence in male sex offenders.
    Wincze JP; Bansal S; Malamud M
    Arch Sex Behav; 1986 Aug; 15(4):293-305. PubMed ID: 3741089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erectile dysfunction in men with diabetes mellitus.
    Maatman TJ; Montague DK; Martin LM
    Urology; 1987 Jun; 29(6):589-92. PubMed ID: 3576882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral trazodone is not effective therapy for erectile dysfunction: a double-blind, placebo controlled trial.
    Costabile RA; Spevak M
    J Urol; 1999 Jun; 161(6):1819-22. PubMed ID: 10332444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperprolactinemia: a possible cause of sexual impotence in male patients undergoing chronic hemodialysis.
    Gura V; Weizman A; Maoz B; Zevin D; Ben-David M
    Nephron; 1980; 26(1):53-4. PubMed ID: 7393379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Erectile dysfunction secondary to hyperprolactinemia. Apropos of 13 cases].
    Abram F; Linke F; Kalfon A; Tchovelidze C; Chelbi N; Arvis G
    Prog Urol; 1998 Sep; 8(4):537-41. PubMed ID: 9834517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased sexual desire with exogenous testosterone administration in men with obstructive sleep apnea: a randomized placebo-controlled study.
    Melehan KL; Hoyos CM; Yee BJ; Wong KK; Buchanan PR; Grunstein RR; Liu PY
    Andrology; 2016 Jan; 4(1):55-61. PubMed ID: 26610430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between nocturnal penile tumescence parameters, International Index of Erectile Function symptom scores and sildenafil responses1This paper was presented at the 6th Congress of the International Society of Sexual and Impotence Research, Buenos Aires, Argentina, 17-21 October 2004.
    Murad Başar M; Tuğlu D; Yilmaz E; Başar H; Batislam E
    Scand J Urol Nephrol; 2006; 40(6):506-10. PubMed ID: 17130103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperprolactinemia and impotence.
    el-Beheiry A; Souka A; el-Kamshoushi A; Hussein S; el-Sabah K
    Arch Androl; 1988; 21(3):211-4. PubMed ID: 3245713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral phosphodiesterase-5 inhibitors and hormonal treatments for erectile dysfunction: a systematic review and meta-analysis.
    Tsertsvadze A; Fink HA; Yazdi F; MacDonald R; Bella AJ; Ansari MT; Garritty C; Soares-Weiser K; Daniel R; Sampson M; Fox S; Moher D; Wilt TJ
    Ann Intern Med; 2009 Nov; 151(9):650-61. PubMed ID: 19884626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improvement of sexual function in men with late-onset hypogonadism treated with testosterone only.
    Yassin AA; Saad F
    J Sex Med; 2007 Mar; 4(2):497-501. PubMed ID: 17367445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Testosterone and impotence--when is androgen substitution advisable?].
    John H
    Ther Umsch; 1998 Jun; 55(6):372-6. PubMed ID: 9658979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of testosterone supplementation on sexual function in hypogonadal men with erectile dysfunction.
    Mulhall JP; Valenzuela R; Aviv N; Parker M
    Urology; 2004 Feb; 63(2):348-52; discussion 352-3. PubMed ID: 14972487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transdermal testosterone gel increases serum testosterone levels in hypogonadal men in Taiwan with improvements in sexual function.
    Chiang HS; Hwang TI; Hsui YS; Lin YC; Chen HE; Chen GC; Liao CH
    Int J Impot Res; 2007; 19(4):411-7. PubMed ID: 17538639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nocturnal penile tumescence activity unchanged after long-term intracavernous injection therapy.
    Maniam P; Seftel AD; Corty EW; Rutchik SD; Hampel N; Althof SE
    J Urol; 2001 Mar; 165(3):830-2; discussion 832-3. PubMed ID: 11176480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of yohimbine hydrochloride on erectile impotence: a double-blind study.
    Susset JG; Tessier CD; Wincze J; Bansal S; Malhotra C; Schwacha MG
    J Urol; 1989 Jun; 141(6):1360-3. PubMed ID: 2657105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.